Register Login

AURORA CANNABIS INC (ACB)

SymbolACB
NameAURORA CANNABIS INC
SectorHEALTH CARE
RegionNorth America
IndustryMedicinal Chemicals & Botanical Products
Address2207 90B STREET SW, EDMONTON, A0 T6X 1V8
Telephone604-362-5207
Fax—
Email—
Websitehttps://www.auroramj.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001683541
Description

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael 71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Additional info from NASDAQ:
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael 71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

2026-07-09 20:35

Aurora Named to TIME Canada’s Best Companies 2026 List

Read more
2026-07-08 12:05

Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders

Read more
2026-06-11 11:50

Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results

Read more
2026-06-11 08:06

New Form 40-F - AURORA CANNABIS INC <b>Filed:</b> 2026-06-11 <b>AccNo:</b> 0001628280-26-042364 <b>Size:</b> 39 MB

Read more
2026-06-02 11:30

Aurora Deepens its Impact for Veterans Across Canada

Read more
2026-05-28 11:35

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call

Read more
2026-04-28 12:25

Aurora Advances Global Medical Cannabis Portfolio

Read more
2026-04-28 12:15

AURORA CANNABIS INC (ACB) Files Form 6-K

Read more
2026-04-16 20:18

AURORA CANNABIS INC (ACB) Files Form 6-K

Read more
2026-04-15 12:08

Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT03522467 Cannabis Oil for Pain Effectiveness Phase2 Cancer Unknown 2018-07-25 2020-09-01 ClinicalTrials.gov
Total clinical trials: 1
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
MRCP001 Other Phase PHASE2 Cancer UNKNOWN NCT03522467
MRCP001 DRUG Phase PHASE2 Cancer UNKNOWN NCT03522467
Total products: 2